What will happen after liver cancer resection

Update Date: 2023-01-19 Source: Network

summary

Some time ago, my uncle often said that he was not feeling well, and that he would cough up blood. He always said that he had a stomachache, and sometimes the pain would be very severe. So accompanied by his family, the hospital carried out an examination and found that it was liver cancer. Even after treatment in the hospital, the patient's condition was under control after a period of treatment, Now I will tell you some questions about liver cancer.

What will happen after liver cancer resection

As long as the diagnosis of liver cancer, postoperative recurrence rate can not say 100%, but should be very high. If it can be more than 5 years after the operation, it should be said that there is not much cure. If you want to open up, because normal people can get liver cancer, let alone once.

The recurrence rate of HCC is high, but recurrence is not inevitable and should be maintained. Since doctors don't recommend chemotherapy, there is no need for chemotherapy. After all, if the immunosuppression caused by chemotherapy is not treated, it is also an important factor to induce the recurrence of liver cancer.

Liver cancer is still a terrible disease, which brings great harm to patients. The recurrence of liver cancer depends on the body's own immune level. Generally speaking, the operation injury, for the body consumption is obvious, so the postoperative immunity is poor, easy to lead to the recurrence and metastasis of liver cancer.

matters needing attention

For patients with liver cancer, we should have a positive and optimistic attitude to the treatment of this disease, and at the same time, we should cooperate with doctors in time to achieve better treatment effect. If liver cancer is in the early stage, it can be operated in time, and can be supplemented with consolidation treatment after operation, the 5-year survival rate will reach more than 70%. The specific survival time depends on the effect of treatment and whether the patient has recurrence and metastasis in the later stage.